NEW YORK (MedscapeWire) Apr 05 — The rheumatoid arthritis drug leflunomide ( Arava) should be banned, a consumer watchdog group says. Leflunomide has been linked to 22 deaths in its first 3 years of ...

Please provide your email address to receive an email when new articles are posted on . In patients with RA not responding to methotrexate, beginning with a biosimilar DMARD was cost-effective vs. a ...

Lyon, France - A case of lupus erythematosus reactivation in a Sjogren's patient treated with leflunomide (Arava, Aventis) is reported in the January 2005 issue of Annals of the Rheumatic Diseases [ 1 ...

Patients with rheumatoid arthritis (RA) treated with leflunomide (Arava) experienced modest but significant weight loss not seen with other RA therapies, a large Veterans Administration study found.

The FDA has updated the Boxed Warning of Arava (leflunomide, from sanofi aventis) to highlight the risk of severe liver injury in patients using this drug and how this risk may be reduced. The Boxed ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

Please provide your email address to receive an email when new articles are posted on . Sanofi announced it has released an authorized generic version of Arava for ...

Arava is a brand-name prescription medication. Its generic version is called leflunomide. Medicare Part D prescription drug plans may cover either version if a doctor or healthcare professional ...

[07-13-2010] The U.S. Food and Drug Administration (FDA) is adding information on severe liver injury to the Boxed Warning of Arava (leflunomide) - a drug used to treat rheumatoid arthritis - to ...

Arava is a brand-name prescription medication for the generic version of leflunomide. Medicare Part D drug plans may cover either version if a doctor or healthcare professional prescribes it. Private ...